OROPHARYNGEAL CANCER
Clinical trials for OROPHARYNGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNGEAL CANCER trials appear
Sign up with your email to follow new studies for OROPHARYNGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation cut by more than half in new throat cancer trial
Disease control Recruiting nowThis study is testing whether a much lower dose of radiation, combined with standard chemotherapy, can effectively control HPV-positive throat cancer while causing fewer side effects. It will involve 121 adults with this specific cancer type who have not had prior radiation to th…
Matched conditions: OROPHARYNGEAL CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Could special imaging help throat cancer patients avoid unnecessary radiation side effects?
Disease control Recruiting nowThis study is testing whether using special imaging to guide radiation treatment to only the affected side of the neck works as well as treating both sides for patients with throat cancer that hasn't spread across the midline. Researchers want to see if this more targeted approac…
Matched conditions: OROPHARYNGEAL CANCER
Phase: PHASE3 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Blood test could spare throat cancer patients from harsh treatments
Disease control Recruiting nowThis study is testing a personalized approach to treatment for people with HPV-linked throat cancer who have had surgery. The goal is to see if a simple blood test can help doctors decide who needs less intense follow-up therapy, aiming to control the cancer while reducing side e…
Matched conditions: OROPHARYNGEAL CANCER
Phase: PHASE2 • Sponsor: Zachary Zumsteg • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo aims to spare cancer patients from disfiguring surgery
Disease control Recruiting nowThis study is testing a new approach for people with advanced head and neck cancer. The goal is to see if giving a combination of chemotherapy and immunotherapy *before* surgery can shrink tumors enough to allow surgeons to perform less extensive operations. This could help prese…
Matched conditions: OROPHARYNGEAL CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Doctors test gentler, tailored treatments for common throat cancer
Disease control Recruiting nowThis study is testing two personalized approaches to treat early-stage throat cancer caused by HPV. The goal is to control the cancer effectively while using less intense treatments to reduce side effects. One approach starts with surgery, and the other uses tailored radiation an…
Matched conditions: OROPHARYNGEAL CANCER
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New combo treatment aims to control aggressive throat cancer
Disease control Recruiting nowThis study is testing a new treatment approach for HPV16-positive throat cancer that has not been treated before. Patients first receive an immunotherapy drug (toripalimab) combined with chemotherapy to shrink the tumor. Based on how well the tumor responds, patients then undergo…
Matched conditions: OROPHARYNGEAL CANCER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New attack on lingering HPV after throat cancer treatment
Disease control Recruiting nowThis study is testing if an immunotherapy drug called balstilimab can clear the HPV virus from the blood of throat cancer patients who have finished their main treatment but still show signs of the virus. The goal is to see if clearing this leftover virus can help prevent the can…
Matched conditions: OROPHARYNGEAL CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Spit test could spot throat cancer sooner
Diagnosis Recruiting nowThis study is testing a new oral swab that looks for specific markers linked to HPV-related throat cancer. The goal is to see if this simple test can accurately find cancer early, when treatment is often more successful. Researchers will compare results from 200 people with throa…
Matched conditions: OROPHARYNGEAL CANCER
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Diagnosis
Last updated Mar 27, 2026 12:39 UTC
-
New approach aims to ease pain and improve recovery after throat cancer surgery
Symptom relief Recruiting nowThis study is testing whether a long-acting numbing medicine, injected directly into the surgical area, can better control pain and help swallowing function after robotic surgery for throat cancer. Researchers will compare patients who receive this injection to those who do not, …
Matched conditions: OROPHARYNGEAL CANCER
Sponsor: Geisinger Clinic • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
Massive cancer database seeks volunteers to help unlock disease secrets
Knowledge-focused Recruiting nowThis study is building a large, long-term database of health information and biological samples from people with cancer, people at risk for cancer, and healthy volunteers. The goal is to collect this data to help researchers better understand what causes cancer and how to prevent…
Matched conditions: OROPHARYNGEAL CANCER
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Blood test could catch Cancer's return before symptoms appear
Knowledge-focused Recruiting nowThis study is testing whether simple 'liquid biopsies'—like blood tests, mouth rinses, and swabs—can help doctors monitor patients after treatment for HPV-related cancers. Researchers want to see if these tests can detect signs that the cancer might be returning much earlier than…
Matched conditions: OROPHARYNGEAL CANCER
Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:53 UTC